Two years progression-free survival under vinorelbine metronomic therapy of a patient with metastatic epithelioid hemangioendothelioma. Monaldi Arch Chest Dis [Internet]. 2022 Apr. 1 [cited 2025 Jun. 7];92(4). Available from: https://www.monaldi-archives.org/macd/article/view/1798